Healthcare

All news articles tagged with "Healthcare"

Showing 1-15 of 15 articles

Regeneron REGN Stock Chart Analysis with technical levels

Regeneron (REGN) Price Action: Trading the $772.50 Mid-Range Pivot

Regeneron shares test critical resistance at $779.78 following earnings strength. Analyze the liquidity tests and price action for the Feb 5 session.

Michael Thompson14 days ago4 min read

Building sign 'Market' for healthcare market analysis & 2026 policy-volatility shift.

Healthcare Market Analysis: Trading the 2026 Policy-Volatility Shift

Healthcare is evolving from a defensive staple into a policy-driven volatility trade as regulatory shifts and pricing scrutiny redefine market regimes.

François Bernard20 days ago4 min read

Takeda Q4 earnings: Stacking coins for TAK pipeline growth & FX strategy.

Takeda (TAK) Q4 Earnings Strategy: Pipeline Mix and FX Impact

Analyzing Takeda's Q4 earnings through the lens of FX translation, pipeline development, and capital allocation for the Jan 29 session.

Lauren Lewis21 days ago3 min read

CAH Q4 Earnings: White concrete building symbolizes Cardinal Health's strategic growth and financial outlook.

Cardinal Health (CAH) Q4 Earnings: Scenario Map and Strategy

Analyzing Cardinal Health (CAH) Q4 earnings with a focus on medical segment margins, distribution economics, and capital allocation strategies.

Megan Walker21 days ago4 min read

Teaming coins for TEVA earnings watch, symbolizing trading pipeline and guidance risk.

TEVA Earnings Watch: Trading Pipeline and Guidance Risk

Teva Pharmaceutical Industries (TEVA) reports Q4 earnings with the market focused on pipeline R&D, litigation overhang, and forward-looking guidance.

Megan Walker22 days ago4 min read

ELV Earnings Watch: Elevance Health Q4 guidance trading, high-rise cityscape.

ELV Earnings Watch: Trading Elevance Health Q4 Guidance

Analyze the trading setup for Elevance Health (ELV) Q4 earnings, focusing on MLR utilization and the 2026 outlook ahead of the New York open.

Megan Walker22 days ago4 min read

CNMD earnings: high-rise buildings symbolize CONMED's financial outlook.

CNMD Earnings Watch: Trading CONMED Pricing and Guidance

CONMED (CNMD) reports Q4 earnings with a focus on pricing dynamics and gross margin recovery amidst input-cost inflation.

Christopher Taylor22 days ago3 min read

JNJ stock chart showing earnings price action

Johnson & Johnson (JNJ) Q4 Earnings: Trading the Margin Bridge

Analyze Johnson & Johnson's earnings through our tactical lens, focusing on guidance specificity and post-call price action for JNJ.

Pierre Moreau24 days ago4 min read

J&J Q4 Earnings Strategy: Scrabble tiles spell 'Trading' for guidance.

J&J Q4 Earnings Strategy: Trading Guidance and Factor Rotation Risk

Johnson & Johnson faces a critical earnings test where guidance credibility and margin bridges will determine its ability to de-couple from broader factor rotation.

Jean-Pierre Leclerc27 days ago3 min read

Stock market chart showing Johnson & Johnson (JNJ) earnings volatility

Johnson & Johnson (JNJ) Q4 Earnings Outlook: MedTech vs Innovative Medicine

Johnson & Johnson (JNJ) kicks off a high-liquidity earnings week as investors weigh MedTech normalization against Innovative Medicine growth segments.

Christopher Taylor29 days ago3 min read

Johnson & Johnson building and financial earnings chart overlay

Johnson & Johnson (JNJ) Q4 Earnings Forecast: Guidance vs. Margin Risks

Analyzing JNJ’s Q4 earnings setup as markets navigate MLK Day liquidity gaps and sector-wide dispersion risks ahead of the Tuesday re-open.

Stefan Weberabout 1 month ago3 min read

Abbott Laboratories (ABT) stock chart analysis and earnings preview

Abbott Laboratories (ABT) Q4 Earnings: Guidance and Margins in Focus

Abbott Laboratories (ABT) prepares to report Q4 2025 results. Explore key support levels, guidance expectations, and margin bridge analysis for the upcoming print.

François Bernardabout 1 month ago3 min read

Johnson & Johnson building and stock chart overlay

Johnson & Johnson (JNJ) Q4 Earnings Preview: Guidance and Pipeline in Focus

Johnson & Johnson (JNJ) prepares to report Q4 2025 results with markets focused on pharmaceutical pipeline cadence and 2026 margin guidance.

Antonio Ricciabout 1 month ago3 min read

Johnson & Johnson JNJ Earnings Forecast and Stock Chart Analysis

Johnson & Johnson (JNJ) Earnings Preview: Defensive Ballast in Focus

As Johnson & Johnson prepares for its upcoming earnings release, investors are looking to the healthcare giant as a critical hedge against market volatility and interest rate uncertainty.

Dimitri Volkovabout 1 month ago3 min read

US healthcare spending charts and fiscal inflation markers

US Healthcare Spending Hits $5.3tn: Inflation and Fiscal Implications

US healthcare spending surged 7.2% to a record $5.3 trillion in 2024, signaling persistent structural inflation and mounting fiscal pressures.

Lauren Lewisabout 1 month ago3 min read

About Healthcare News

Stay informed with our comprehensive coverage of healthcare topics. Our expert analysts provide timely insights and in-depth news to help traders and investors navigate the financial markets with confidence.